25: PTC Online Resource Library
There are many resources available on-line about all aspects of cancer (fewer specifically devoted to post-transplant risks, but other information would still be applicable for post-transplant issues), some of which are listed here:
Note: this is just a raw growing collection that will be reorganized in a near future update, but we wanted to make these available for those who may be ready to delve deeper now - stay tuned as new links are added regularly
TRIO Post-transplant Cancer workshop slide set:
Slides used at 2016 TGA (Transplant Games of America) PTC workshop
Cancer general resources:
- National Cancer Institute
- Cancer Research Institute
- Cancer Research Institute
- American Cancer Society
- Clinical Trials
- Cancer Treatment Centers of America
- Cancer in America (PublicHealth.org) also: http://www.publichealth.org/public-awareness/cancer/additional-resources/
- Cancer journals, Courseware, Research organizations, Professional organizations and Public Awareness organizations (PublicHealth.org)
- Israel Penn International Transplant Tumor Registry (and here's a link to their publications)
- American Institute for Cancer Research: Tools You Can Use
- AICR: Cancer Infographics & Multimedia (an educational resource)
- AICR: Cancer Prevention 30 day planner PDF
- US Government booklet for Cancer Survivors PDF download
- Cancer Screening Guidelines by Age
- What to Expect During Your Prostate Exam
- Skin Cancer Screening: What to Expect
- What to Expect During, Before, and After Radiation Treatment
- Cancer Causing Agents - Carcinogens
- Coping with Cancer: 10 Steps Towards Emotional Well-Being
- What are the Short and Long Term Side Effects of Chemotherapy?
- Skin cancer common after organ transplant (1/11/2017 article)
- FREE Cancer Resource: Living with Cancer 10/20/2017
Cancer articles & videos of interest:
- FREE PDF download by CRI: Cancer and the Immune System: The Vital Connection 12/1/2017
- FDA approves a game-changing treatment for blood cancer 10/19/2017
- 15 Cancer Symptoms Women Are Likely to Ignore 10/18/2017
- PTSD and Life After Cancer 10/11/2017
- 7 Side Effects of Cancer Treatment and How to Cope With Them 10/17/2017
- Eating Well During and After Your Cancer Treatment 10/11/2017
- Living with Cancer: Eight Things You Need to Know 10/11/2017
- Sleep and cancer (TUCK web article with related ressource links)
- Cancer's Invasion Equation (by the same author of the fascinating book, The Emperor of All Maladies, A Biography of Cancer) 9/5/2017
- There's a New Way to Treat Cancer! 9/1/2017
- Cancer's Newest Miracle Cure
- Melanoma Risk Higher in Kidney Transplant Recipients
- 6 Findings on Exercise and Cancer Risk
- Surprising Facts About Melanoma
- Study finds low rate of cancer screening among transplant patients
- Skin Cancer in Heart Transplant Recipients: Risk Factor Analysis and Relevance of Immunosuppressive Therapy (study from 2000)
- Transplant Patients Have More Infections After Mohs Surgery
- Scientists usher in new era of cancer research
- Study: African-American Organ Transplant Recipients at Risk for Skin Cancer
- Inconsistent guidelines for screening transplant recipients at higher cancer risk: Canadian study
- Immunosuppressed Melanoma Patients Have More Aggressive Disease
- Animated Introduction to Cancer Biology (video)
- 4 Rays of Hope for 'Precision' Cancer Therapies
- Most Cancer Is Beyond Your Control, Breakthrough Study Finds
- More Evidence of Exercise for Cancer Prevention
- The Nutrition Label, "Healthy' and Cancer Prevention
- 3 Steps for Cancer Survivors to Live Healthier
- Harvesting the Immune System to Fight Cancer
- What is Immunotherapy? The Basics on These Cancer Treatments
Gengraf, Neoral, Sandimmune (generic name: cyclosporine)
Hecoria, Prograf, Astagraf XL (generic name: tacrolimus)
Afinitor, Afinitor Disperz, Zortress (generic name: everolimus)
Torisel (generic name: temsirolimus)
Rapamune (generic Name: sirolimus)
Cancer in Transplant Recipients
- Cancer in the Transplant Recipient - Jeremy R. Chapman, Angela C. Webster and Germaine Wong
- RNA sequencing characterized high-risk squamous cell carcinomas
- National Cancer Institute: Transplant Cancer Match Study
- ITNS Skin Cancer booklet (PDF download)
- American Academy of Dermatology
- International Transplant Skin Cancer Collaborative (. . . and click here for a link to their publications)
- Mollie's Fund (Melanoma/tanning)
- Renal Cell Carcinoma (42 slides)
- Newspaper article on Crowdfunding: http://www.nbcnews.com/nightly-news/how-crowdfunding-helps-patients-deal-high-cost-cancer-care-n370176
- The Leukemia & Lymphoma Society - for help or to learn more about specific blood cancers: www.lls.org/diseaseinformation/
- Proceedings from 2012 ITSCC conference: http://www.itscc.org/UserFiles/file/Cummins%2520ITSCC%2520Presentation.pdf
- Int J Cancer. 2013 Mar 15;132(6):1429-38. doi: 10.1002/ijc.27765. Epub 2012 Aug 28: Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.
- Am J Transplant. 2013 Jan;13(1):174-83. doi: 10.1111/j.1600-6143.2012.04302.x. Epub 2012 Oct 24. Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients.
- Harris JP, Penn I: Immunosuppression and development of malignancies of the upper airway. Laryngoscope 91:520–528, 1981.
- Immunosuppression and Merkel cell cancer. Translant Proc 2002 Aug;34(5):1780–1
- Penn I, Brunson ME: Cancers following cyclosporine therapy. Transplant Proc 20 (Suppl 3):885–892, 1988.
- Penn I, First MR: Development and incidence of cancer following cyclosporine therapy. Transplant Proc 18:210–213, 1986.
- Penn I, Starzl TE: Immunosuppression and cancer. Transplant Proc 5:943–947, 1973.
- Penn I, Starzl TE: Immunosuppression and neoplasia. ALG Therapy and Standardization Workshop. Behring Institute Research Communications No. 51, Behring-Werke, Marburg, West Germany. (ed Seiler FR and Schwick HG) pp. 204–208, 1972.
- Penn I, Starzl TE: The effect of immunosuppression on cancer. In Seventh National Cancer Conference Proceedings. Philadelphia, J.B. Lippincott Co., pp. 425–436, 1973.
- Penn I: Cancer associated with immunosuppression. Chapter in CRC Handbook Series in Clinical Laboratory Science. Section F: Immunology Vol. 1, Part 2 (eds Baumgarten A and Richards FF) Cleveland, Ohio CRC Press Inc., pp. 365–375, 1979.
- Penn I: Cancer following cyclosporine therapy. Transplant Proc 19:2211–2213, 1987.
- Penn I: Cancer in immunosuppressed patients. In Symposia Medica Hoechst 21 The Nature, Cellular and Biochemical Basis and Management of Immunodeficiencies. (eds Good RA and Lindenlaub E). F.K. Shattauer Verlag, Stuttgart, pp. 271–288, 1987.
- Penn I: Cancer in immunosuppressed patients. Transplant Proc 16:492–494, 1984.
- Penn I: Cancer in immunosuppressed patients. Transplant Proc 7 (Suppl. 1) 553–555, 1975.
- Penn I: Cancer in the immunosuppressed organ recipient. Transplant Proc 23:1771–1772, 1991.
- Penn I: Cancer is a long-term hazard of immunosuppressive therapy. In Immunointervention in Autoimmune Diseases (ed Bach JF). London Academic Press, pp. 49–62, 1989.
- Penn I: Cancer is a long-term hazard of immunosuppressive therapy. J Autoimmunity 1:545–558, 1988.
- Penn I: Cancers after cyclosporine therapy. Transplant Proc 20(Suppl):276–279, 1988.
- Penn I: Cancers following cyclosporine therapy. Transplantation 43:32–34, 1987.
- Penn I: Chemical immunosuppression and human cancer. Cancer 34:1474–1480, 1974.
- Penn I: Cyclosporine and oncogenesis. Mount Sinai J Med 54:460–464, 1987.
- Penn I: Depressed immunity and the development of cancer: A review. Clin Exp Immunol 46:459–474, 1981.
- Penn I: Immunosuppression and cancer: Importance in head and neck surgery. Arch Otolaryngol 101:667–670, 1975.
- Penn I: Immunosuppression and malignant disease. Chapter in Comprehensive Immunology — 4 — The Immunopathology of Lymphoreticular Neoplasms (eds Twomey JJ and Good RA) Plenum Medical Book Company, New York, pp. 223–237, 1978.
- Penn I: Immunosuppression and opportunistic tumors: Do viruses play a role? In Advances in tumor immunology and allergic disorders, Immuno Incontri (ed F. Dammacco). Milan, Edi. Ermes, pp. 139–162, 1992
- Penn I: Immunosuppressive agents, immunodeficiency states and malignancy. In Lieberman R and Mukherjee A (Eds), Principles of Drug Development in Transplantation and Autoimmunity, Austin, Texas, RG Landes, New York, Chapman and Hall, pp. 93–102, 1996.
- Penn I: Malignancies associated with immune deficiencies. In Comprehensive Textbook of Oncology, (eds Moossa AR, Schimpf SC and Robson MC), Second Edition Baltimore, Williams and Wilkins Co., pp. 115–119, 1991.
- Penn I: Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83:492–502, 1978.
- Penn I: Malignancies following the use of Cyclosporin A in man. Cancer Surveys 1(4):621–624, 1983.
- Penn I: Malignant disease in immunodeficient states in man. In Recent Results in Cancer Research (eds Grundmann E and Gross R) Vol. 52:96–106, 1975.
- Penn I: Malignant neoplasia in the immunocompromised patient. In The Transplantation and Replacement of Thoracic Organs. The present status of biological and mechanical replacement of the heart and lungs. (eds Cooper DKC and Novitzky D) Dordrecht Kluwer Academic Publishers, pp. 183–190, 1990.
- Penn I: Mechanisms of therapy induced malignancies — editorial review. Cancer Surveys 1(4):763–782, 1983.
- Penn I: Neoplastic consequences of immunosuppression. In Immunotoxicology and Immunopharmacology. (eds Dean JH, Luster MI, Munson AE, Amos H) New York, Raven Press, pp. 79–89, 1985.
- Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1998:147–58.
- Penn I: Occurrence of cancers in immunosuppressed organ transplant recipients. In Clinical Transplants 1994, Terasaki PI and Cecka JM (Eds). UCLA Tissue Typing Laboratory, pp. 99–109, 1995.
- Penn I: Occurrence of malignancies in immunosuppressed organ transplant recipients. In Organ Transplantation 1990 (eds Abouna GM, Kumar MSA, White AG). Dordrecht, Kluwer Academic Publishers, pp. 475–483, 1991.
- Penn I. Post-transplant malignancy: the role of immunosuppression. Drug Saf. 2000 Aug;23(2):101–13.
- Penn I: Second malignant neoplasms associated with immunosuppressive medications. Cancer 37:1024–1032, 1976.
- Penn I: The neoplastic consequences of immunodepression. In Immunotoxicology. (eds Berlin A, Deal J, Draper MH, Smith EMB, Spreafico F). Dordrecht, Martinus Nijhoff Publishers, pp. 69–82, 1987.
- Penn I: The occurrence of cancer in immune deficiencies. Current Problems in Cancer 6(10) 1–64, April 1982.
- Penn I: The occurrence of malignant tumors in immunosuppressed states. In Acquired Immunodeficiency Syndrome (ed Klein E) Basel, Karger. (Progress in Allergy Series) Vol. 37, pp. 259–300, 1986.`
- Penn I: Why do immunosuppressed patients develop cancer? In CRC Critical Reviews in Oncogenesis (ed Pimentel E). Boca Raton, Florida CRC Press Inc., Vol. 1, pp. 27–52, 1989.
- Porreco R, Penn I, Droegemueller W, Greer B, Makowski E: Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynec 45:359–364, 1975.
- Schwartz RS, Penn I: Immunosuppression and neoplasia. Transplant Proc 7 (Suppl. 1) 899–900, 1975.
- Starzl TE, Penn I, Halgrimson CG: Immunosuppression and malignant neoplasms. (letter to the editor) New Eng J Med 283:934, 1970.
- The role of immunosuppression in lymphomas. Recent Results Cancer Res 2002;159:55–66. Review.
- Yakupoglu YK, Buell JF, Woodle S, Kahan BD. Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy. Transplant Proc. 2006;38(2):358–61.
(click on title above to learn more about this collaborative study that produced the papers listed below)
- Morton LM, Gibson TM, Clarke CA, Lynch CF, Anderson LA, Pfeiffer R, Landgren O, Weisenburger DD, Engels EA. Risk of myeloid neoplasms after solid organ transplantation. Leukemia. 2014 Dec;28(12):2317-23.
- Wetmore JB, Calvet JP, Yu AS, Lynch CF, Wang CJ, Kasiske BL, Engels EA. Polycystic kidney disease and cancer after renal transplantation. J Am Soc Nephrol. 2014 Oct;25(10):2335-41.
- Koshiol J, Pawlish K, Goodman MT, McGlynn KA, Engels EA. Risk of hepatobiliary cancer after solid organ transplant in the United States. Clin Gastroenterol Hepatol. 2014 Sep;12(9):1541-9.
- Gibson TM, Engels EA, Clarke CA, Lynch CF, Weisenburger DD, Morton LM. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. Am J Hematol. 2014 Jul;89(7):714-20.
- Engels EA, Castenson D, Pfeiffer RM, Kahn A, Pawlish K, Goodman MT, Nalesnik MA, Israni AK, Snyder J, Kasiske B. Cancers among US organ donors: a comparison of transplant and cancer registry diagnoses. Am J Transplant. 2014 Jun;14(6):1376-82.
- Morton LM, Gibson TM, Clarke CA, Lynch CF, Weisenburger DD, Engels EA. Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipients. Haematologica. 2014 May;99(5):70-3.
- Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant. 2013 Dec;13(12):3202-9.
- Hall EC, Engels EA, Montgomery RA, Segev DL. Cancer risk after ABO-incompatible living-donor kidney transplantation. Transplantation. 2013 Sep 15;96(5):476-9.
- Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, Weisenburger DD, Martínez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA. Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer. 2013 Jul 9;109(1):280-8.
- Engels EA, Clarke CA, Pfeiffer RM, Lynch CF, Weisenburger DD, Gibson TM, Landgren O, Morton LM. Plasma cell neoplasms in US solid organ transplant recipients. Am J Transplant. 2013 Jun;13(6):1523-32.
- Hall EC, Pfeiffer RM, Segev DL, Engels EA. Cumulative incidence of cancer after solid organ transplantation. Cancer. 2013 Jun 15;119(12):2300-8.
- Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD, Lynch CF, Goodman MT, Engels EA. Burkitt lymphoma risk in U.S. solid organ transplant recipients. Am J Hematol. 2013 Apr;88(4):245-50.
- Hall EC, Segev DL, Engels EA. Racial/ethnic differences in cancer risk after kidney transplantation. Am J Transplant. 2013 Mar;13(3):714-20.
- Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011 Nov 2;306(17):1891-901.